SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jman who wrote (18278)1/28/1999 6:37:00 PM
From: RealMuLan  Read Replies (1) of 23519
 
Jman: you're welcome. The problem is that the company'd better guided down the First Call estimates, which is now at 13 cents. Everybody will be better off to start from low point, and then give some surprise, like this quarter. Otherwise, in this kind small-cap-company-being-killed market, a company like VVUS cannot survive. Look what happened to Administaff. They missed 4 cents in earning, got 27 cents vs. 31 estimates. The stock went down >50% in just one day. Vast majority of the stock market gain went to a small handful,
30-60, big companies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News